• Juergen Behr, Marius M Hoeper, Michael Kreuter, Jens Klotsche, Hubert Wirtz, and David Pittrow.
• Department of Internal Medicine V , Comprehensive Pneumology Center, University of Munich and Asklepios Fachkliniken München-Gauting , Munich , Germany.
• BMJ Open Respir Res. 2014 Jan 1;1(1):e000010.

BackgroundGuidelines on the diagnosis and management of idiopathic pulmonary fibrosis (IPF), a rare manifestation of chronic progressive fibrosing interstitial pneumonia, have been updated by ATS/ERS/JRS/ALAT in 2011. In Europe, data are limited on the characteristics and management of such patients.Methods/DesignInvestigating significant health trends (INSIGHTS)-IPF is a prospective observational longitudinal registry designed to describe the characteristics and management of newly diagnosed (incident) and prevalent patients with IPF on the long term. The registry uses a non-probability sampling approach to collect data on characteristics, therapeutic interventions, health-related quality of life and health economic parameters. At least 500 patients in ambulatory care will be included consecutively in about 30 centres. The study has been initiated in November 2012, and currently (December 2013) follows 344 patients. ClinTrials.gov identifier is NCT01695408.DiscussionINSIGHTS-IPF documents one of the largest IPF cohorts in Europe. The registry is expected to provide much-needed data on the characteristics and management situation of patients with IPF in Germany. It will allow comparisons with other countries. Gap analyses based on current guidelines for management of these patients will be possible.

2 keywords...

hide…